Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 1-10 of 72

Page
per page
  1. MNI-caged-D-aspartate
    B5286 MNI-caged-D-aspartate
    Summary: Agonist at NMDA receptors and EAAT substrate
      <3.09 mg/mL
  2. PPDA
    B5312 PPDA
    Summary: Subtype-selective NMDA receptor antagonist
  3. TCN 201
    B5535 TCN 201
    Summary: NR1/NR2A selective NMDA receptor antagonist
      Soluble in DMSO
  4. TCN 213
    B5536 TCN 213
    Summary: NR1/NR2A selective NMDA receptor antagonist
      <28.24 mg/mL
  5. DQP 1105
    B5620 DQP 1105
    Summary: NMDA receptor antagonist
      <55.84 mg/mL
  6. QNZ 46
    B5718 QNZ 46
    Summary: NR2C/NR2D-selective NMDA receptor antagonist
      ≥6.2 mg/mL
  7. LY 233053
    B5124 LY 233053
    Summary: Competitive NMDA receptor antagonist
      <21.12 mg/mL
  8. D-AP5
    B6205 D-AP5
    Summary: NMDA antagonist
      insoluble in DMSO; insoluble in EtOH; ≥28.1 mg/mL
  9. (+)-MK 801 Maleate
    A8896 (+)-MK 801 Maleate
    Summary: Potent NMDA antagonist
      ≥16.85 mg/mL
  10. Lanicemine
    C3205 Lanicemine
    Summary: voltage-dependent NMDA channel blocker
      ≤20 mg/mL

Items 1-10 of 72

Page
per page
Relate Categories
Now Shopping by
  1. Category NMDA Receptor Remove This Item
Clear All